HIV injections work better than tablets for young people
Young people living with HIV manage their condition better when their antiretroviral therapy is given by injections every eight weeks, rather than in the form of daily tablets, according to results from the LATA trial.
18 Sep
Alpha-lipoic acid shows ‘early promise’ to treat progressive multiple sclerosis
Early results from OCTOPUS trial suggest that alpha-lipoic acid shows early promise as a treatment to protect nerves for progressive MS.
17 Sep
Our methodology research at ICTMC 2026
Our trial methodology researchers will have a large turnout at the 8th International Clinical Trials Methodology Conference in Birmingham, UK.
09 Sep
Long-acting injectable treatment better than daily tablets for young people living with HIV
Having injections every 8 weeks was better at keeping HIV under control than daily tablets among young people living with HIV, according to results from the LATA trial.
29 Jul
Cancer
Innovative clinical trial design and meta-analysis extending beyond the boundaries of single cancer types
Infections
Major international clinical trials answering questions of global public health significance
Neurodegenerative diseases
New generation of innovative multi-arm multi-stage trials to identify and test new therapeutic treatments in neurodegenerative diseases (NDD)
Methodology
Development of methods with direct impact on the design, conduct and analysis of studies
Other Research & Policy
This section will capture projects outside the current QQR themes
Listen to the PediCAP trial episode by clicking the image below or this link to listen on SoundCloud.